+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Clinical Trial Imaging Market by Product & Service (Services, Software), Modality (Computed Tomography, Echocardiography, Magnetic Resonance Imaging), Therapeutic area, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 190 Pages
  • March 2025
  • Region: Global
  • 360iResearch™
  • ID: 5470713
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Clinical Trial Imaging Market grew from USD 1.31 billion in 2023 to USD 1.39 billion in 2024. It is expected to continue growing at a CAGR of 6.68%, reaching USD 2.06 billion by 2030.

In today’s rapidly evolving medical environment, clinical trial imaging has emerged as a critical tool that bridges advanced technology and patient care in research settings. This industry is defined by its pursuit of precision, enhanced methodologies, and breakthrough innovations, all of which contribute to improved outcomes in clinical trials. The integration of sophisticated imaging techniques into clinical research plays a pivotal role in enhancing data accuracy, streamlining trial processes, and ultimately, bringing life-changing therapies to market faster.

Recent advancements in imaging technology have fostered a deeper understanding of disease mechanisms and accelerated the development of personalized treatment plans. These improvements have not only elevated diagnostic accuracy but have also ensured that clinical trials are executed with a heightened sense of efficiency and precision. As the sector adapts to contemporary demands, organizations are constantly exploring new approaches that challenge traditional methods while remaining anchored in rigorous scientific validation.

Through this comprehensive examination, our analysis delves into the intricacies of clinical trial imaging, shedding light on emerging trends, evolving market paradigms, and industry disruptions that promise to reshape the landscape. Our insight provides stakeholders with the necessary knowledge to navigate this transformative era, underscoring how a detailed understanding of clinical trial imaging can expedite research innovations while maintaining the highest standards of patient care.

Transformative Shifts in the Clinical Trial Imaging Ecosystem

The clinical trial imaging field is undergoing dramatic shifts driven by groundbreaking technological advancements and a growing emphasis on precision medicine. There is an observable trend towards leveraging artificial intelligence and machine learning algorithms that enhance image analysis accuracy. As these technologies become an integral part of trial designs, traditional imaging methodologies are being reinvented to support faster and more reliable diagnostics.

Additionally, the integration of advanced analytics and cloud-based data management platforms is transforming how imaging data is acquired, shared, and analyzed across multi-center trials. This evolution is creating a more cohesive and transparent framework for clinical experiments. Alongside these improvements, industry leaders have recognized the importance of adopting flexible and scalable operational models to ensure that the heightened expectations of regulatory bodies and emerging health crises are met with agility and precision.

These transformative shifts underscore a broader movement within the industry: the redefinition of standards that once governed imaging protocols. Market leaders are now engaged in a continuous process of reassessment and realignment to better mirror the realities of modern clinical research. This paradigm shift is not just a reflection of technological upgrades but also an indication of the industry's commitment to harnessing innovative solutions to improve trial efficiency, reduce operational risk, and ultimately deliver better patient outcomes.

Key Insights Derived from Market Segmentation Analysis

A deep dive into market segmentation insights reveals a layered structure that offers a clearer perspective on the drivers and nuances of the clinical trial imaging market. The analysis is intricately broken down by product and service, modality, therapeutic area, and end-user. In terms of product and service, the market is scrutinized across both services and software, with a further exploration into specific service areas that include operational imaging services, read analysis services, system and technical support services, and trial design and consulting services. This granularity offers practitioners the ability to target innovations and improvements in specialized service segments that are critical in enhancing operational efficiency.

When considering modality, the focus is placed on several advanced imaging techniques, including computed tomography, echocardiography, magnetic resonance imaging, positron emission tomography, ultrasound, and x-ray. Each modality caters to unique aspects of clinical research and patient diagnostics, and their continued evolution is a strong influencer of trial outcomes. In addition, the therapeutic area segmentation highlights key areas of focus such as endocrinology, immunological disorders, infectious diseases, neurology, and oncology. These therapeutic areas represent the frontline of clinical research, where accurate and timely imaging results can significantly impact the interpretation of therapeutic efficacy. Finally, the segmentation by end-user examines the deployment of imaging technologies across academic and government research institutes, biotechnology companies, and organizations such as contract research organizations and pharmaceutical companies. This multidimensional segmentation emphasizes that success in the field is dependent on understanding how various components and stakeholders are interconnected while driving innovation and clinical excellence.

Based on Product & Service, market is studied across Services and Software. The Services is further studied across Operational Imaging Services, Read Analysis Services, System & Technical Support Services, and Trial Design & Consulting Services.

Based on Modality, market is studied across Computed Tomography, Echocardiography, Magnetic Resonance Imaging, Positron Emission Tomography, Ultrasound, and X-Ray.

Based on Therapeutic area, market is studied across Endocrinology, Immunological Disorder, Infectious Diseases, Neurology, and Oncology.

Based on End-User, market is studied across Academic & Government Research Institutes, Biotechnology Companies, Contract Research Organizations, and Pharmaceutical Companies.

Core Regional Insights Across Global Markets

Analyzing the market on a regional basis reveals distinctive trends and growth patterns across key geographies. In the Americas, advancements in clinical trial imaging are bolstered by significant investments in research and development. This dynamic environment is supported by a well-established healthcare infrastructure and robust regulatory frameworks that stimulate innovation. Stakeholders in this region have witnessed steady incorporation of advanced imaging technologies, which have increased efficiency in multi-site observational and interventional trials.

Across Europe, the Middle East, and Africa, regulatory reforms and collaborations between academic institutions and industry have been critical in accelerating the adoption of clinically relevant imaging tools. This geographical area emphasizes a balanced approach between high-end technological implementations and adherence to a stringent quality control mechanism. Meanwhile, the Asia-Pacific region is emerging as a formidable player in clinical trial imaging, rapidly catching up with established markets. Driven by increasing healthcare expenditures, a rise in clinical research activities, and a growing pool of skilled professionals, the region is marked by its dynamic regulatory environment and innovative market entrants. The disparate yet complementary dynamics of these regions collectively contribute to an increasingly competitive global market landscape.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Emerging Insights from Leading Industry Players

A review of market data highlights several key companies that are making significant contributions to the clinical trial imaging domain. Notable organizations include Alimentiv Inc., Anagram 4 Clinical Trials, Biospective Inc., and Boston Imaging Core Lab LLC, all of which have strategically advanced their offerings to cater to a broad range of clinical trial requirements. Other prominent players such as Cardiovascular Imaging Technologies LLC, Clario, and GE HealthCare Technologies Inc. have demonstrated sustained innovation, particularly in the integration of new imaging modalities and support systems. Research-centric entities like Icon PLC, Image Core Lab Private Limited, and Imaging Endpoints II LLC are complementing the market dynamics by offering specialized services that enhance trial design and data interpretation.

Additional leaders like Ixico PLC, Median Technologies, Medical Metrics Inc. by Catalent, Inc., and Medidata by Dassault Systèmes underscore the diverse approaches taken by companies to optimize imaging performance. Corporations such as Medpace, Inc., Micron Inc., and Perceptive Informatics LLC have honed their services on strategic operational improvements. Furthermore, these developments are enhanced by contributions from ProScan Imaging LLC, Resonance Health Ltd., Voiant Clinical, and WCG Clinical, Inc., each of whom plays a vital role in refining procedural workflows, ensuring data integrity, and boosting operational success in clinical research. Together, these companies are sculpting a future in which clinical trial imaging is both a cornerstone of precision medicine and an engine for progressive industry transformation.

The report delves into recent significant developments in the Clinical Trial Imaging Market, highlighting leading vendors and their innovative profiles. These include Alimentiv Inc., Anagram 4 Clinical Trials, Biospective Inc., Boston Imaging Core Lab LLC, Cardiovascular Imaging Technologies LLC, Clario, GE HealthCare Technologies Inc., Icon PLC, Image Core Lab Private Limited, Imaging Endpoints II LLC, Ixico PLC, Median Technologies, Medical Metrics Inc. by Catalent, Inc., Medidata by Dassault Systèmes, Medpace, Inc., Micron Inc., Perceptive Informatics LLC, ProScan Imaging LLC, Resonance Health Ltd., Voiant Clinical, and WCG Clinical, Inc..

Actionable Recommendations for Industry Leaders

Industry leaders are encouraged to harness the latest technological advancements by integrating state-of-the-art imaging systems and data analytics platforms into their clinical trial operations. Embracing digital transformation is critical; investment in artificial intelligence and machine learning applications can significantly streamline data processing and improve image quality. Leaders should focus on strategic collaborations with technology vendors and research institutions to stay ahead of regulatory changes and evolving patient needs.

A proactive approach is recommended to ensure that operational frameworks are not only scalable but also resilient in face of sudden disruptions. This includes overhauling traditional methodologies, enhancing cybersecurity for sensitive medical data, and fostering continuous professional development for staff involved in imaging analysis. By aligning operational strategies with market trends such as modular service offerings and integrated software solutions, companies can create robust pipelines that anticipate challenges and leverage emerging opportunities. Ultimately, the development of an agile, collaborative, and technology-driven culture will be essential to maintain a competitive edge and deliver improved patient outcomes over the long term.

Paving the Way Forward in Clinical Trial Imaging

In summary, the clinical trial imaging industry is undergoing a transformative phase, characterized by technological innovation and a reimagining of traditional clinical research paradigms. Our comprehensive analysis reflects the intricate dynamics of market segmentation, revealing how nuanced differentiators across product and service offerings, imaging modalities, therapeutic areas, and end-user segments are driving competitive advancements. Regional insights further highlight that while established markets continue to innovate steadily, emerging markets are rapidly gaining momentum, fueled by increased investments and evolving regulatory landscapes.

As the industry continues to evolve, successful market players are those who embrace innovation, invest in cutting-edge technology, and nurture strategic partnerships. The convergence of advanced imaging techniques with robust data management systems is not only redefining the process of clinical trials but is also setting new standards for precision and efficiency in patient care. Ultimately, a well-integrated approach that combines technological advancement with strong operational frameworks will be crucial for all stakeholders as they steer through the complexities of modern clinical research.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of chronic diseases and cancer worldwide
5.1.1.2. Increasing emphasis on precision medicine for the adoption of advanced imaging techniques
5.1.2. Restraints
5.1.2.1. High cost associated with the imaging techniques and shortage of skilled personnel
5.1.3. Opportunities
5.1.3.1. Integration of artificial intelligence (AI) to minimize errors and maximize efficiency
5.1.3.2. Increasing investments and funding for the expansion of clinical trial imaging technology
5.1.4. Challenges
5.1.4.1. Ethical concerns around privacy and consent in clinical trial imaging
5.2. Market Segmentation Analysis
5.2.1. Product & Service: Increasing advancements in clinical trial imaging service offerings
5.2.2. Modality: Growing preference for computed tomography for quick imaging capability and detailed cross-sectional views
5.2.3. Therapeutic area: Pivotal role of clinical trial imaging across diverse therapeutic areas and its evolving applications
5.2.4. End-User: Rising demand of clinical trial imaging in academic & government research institutes
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Clinical Trial Imaging Market, by Product & Service
6.1. Introduction
6.2. Services
6.2.1. Operational Imaging Services
6.2.2. Read Analysis Services
6.2.3. System & Technical Support Services
6.2.4. Trial Design & Consulting Services
6.3. Software
7. Clinical Trial Imaging Market, by Modality
7.1. Introduction
7.2. Computed Tomography
7.3. Echocardiography
7.4. Magnetic Resonance Imaging
7.5. Positron Emission Tomography
7.6. Ultrasound
7.7. X-Ray
8. Clinical Trial Imaging Market, by Therapeutic area
8.1. Introduction
8.2. Endocrinology
8.3. Immunological Disorder
8.4. Infectious Diseases
8.5. Neurology
8.6. Oncology
9. Clinical Trial Imaging Market, by End-User
9.1. Introduction
9.2. Academic & Government Research Institutes
9.3. Biotechnology Companies
9.4. Contract Research Organizations
9.5. Pharmaceutical Companies
10. Americas Clinical Trial Imaging Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Clinical Trial Imaging Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Clinical Trial Imaging Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. DeepHealth partners with HOPPR to revolutionize cancer detection with advanced AI imaging models
13.3.2. Subtle Medical revolutionizes clinical imaging with NIH-funded AI tech for enhanced brain MRI efficiency
13.3.3. GE HealthCare's strategic acquisition to enhance AI capabilities in ultrasound imaging precision
13.3.4. Strategic partnership between Voiant and Thirona to revolutionize AI imaging in pulmonary clinical trials
13.3.5. RapidAI's expansion into Japan marks a significant milestone in clinical trial imaging innovation
13.3.6. Aidoc invests USD 30 million to advance comprehensive AI models revolutionizing precision in medical imaging
13.3.7. Altis Labs' global initiative using AI digital twins to transform cancer clinical trial design
13.3.8. WCG partners with Mint Medical to revolutionize imaging workflows in oncology clinical trials for enhanced data precision
13.3.9. Clario introduces a cloud-based image viewer for real-time data access
13.4. Strategy Analysis & Recommendation
13.4.1. Clario
13.4.2. WCG Clinical, Inc.
13.4.3. Ixico PLC
13.4.4. Icon PLC
List of Figures
FIGURE 1. CLINICAL TRIAL IMAGING MARKET MULTI-CURRENCY
FIGURE 2. CLINICAL TRIAL IMAGING MARKET MULTI-LANGUAGE
FIGURE 3. CLINICAL TRIAL IMAGING MARKET RESEARCH PROCESS
FIGURE 4. CLINICAL TRIAL IMAGING MARKET SIZE, 2023 VS 2030
FIGURE 5. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 6. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2023 VS 2030 (%)
FIGURE 11. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
FIGURE 13. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 15. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 19. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. CLINICAL TRIAL IMAGING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 25. CLINICAL TRIAL IMAGING MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CLINICAL TRIAL IMAGING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. CLINICAL TRIAL IMAGING MARKET DYNAMICS
TABLE 7. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY OPERATIONAL IMAGING SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY READ ANALYSIS SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY SYSTEM & TECHNICAL SUPPORT SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY TRIAL DESIGN & CONSULTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY ECHOCARDIOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY X-RAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY IMMUNOLOGICAL DISORDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 49. CANADA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 50. CANADA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 51. CANADA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 52. CANADA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 53. CANADA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. MEXICO CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 55. MEXICO CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 56. MEXICO CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 57. MEXICO CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 58. MEXICO CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 66. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 68. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 71. AUSTRALIA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 72. AUSTRALIA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 73. AUSTRALIA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 74. AUSTRALIA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 75. AUSTRALIA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 76. CHINA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 77. CHINA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 78. CHINA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 79. CHINA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 80. CHINA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. INDIA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 82. INDIA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 83. INDIA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 84. INDIA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 85. INDIA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 86. INDONESIA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 87. INDONESIA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 88. INDONESIA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 89. INDONESIA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 90. INDONESIA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. JAPAN CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 92. JAPAN CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 93. JAPAN CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 94. JAPAN CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 95. JAPAN CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. MALAYSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 97. MALAYSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 98. MALAYSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 99. MALAYSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 100. MALAYSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. PHILIPPINES CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 102. PHILIPPINES CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 103. PHILIPPINES CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 104. PHILIPPINES CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 105. PHILIPPINES CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 106. SINGAPORE CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 107. SINGAPORE CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 108. SINGAPORE CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 109. SINGAPORE CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 110. SINGAPORE CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 111. SOUTH KOREA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 112. SOUTH KOREA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 113. SOUTH KOREA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 114. SOUTH KOREA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 115. SOUTH KOREA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 116. TAIWAN CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 117. TAIWAN CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 118. TAIWAN CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 119. TAIWAN CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 120. TAIWAN CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 121. THAILAND CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 122. THAILAND CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 123. THAILAND CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 124. THAILAND CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 125. THAILAND CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. VIETNAM CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 127. VIETNAM CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 128. VIETNAM CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 129. VIETNAM CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 130. VIETNAM CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 137. DENMARK CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 138. DENMARK CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 139. DENMARK CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 140. DENMARK CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 141. DENMARK CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. EGYPT CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 143. EGYPT CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 144. EGYPT CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 145. EGYPT CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 146. EGYPT CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 147. FINLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 148. FINLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 149. FINLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 150. FINLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 151. FINLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 152. FRANCE CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 153. FRANCE CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 154. FRANCE CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 155. FRANCE CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 156. FRANCE CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 157. GERMANY CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 158. GERMANY CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 159. GERMANY CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 160. GERMANY CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 161. GERMANY CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 162. ISRAEL CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 163. ISRAEL CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 164. ISRAEL CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 165. ISRAEL CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 166. ISRAEL CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 167. ITALY CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 168. ITALY CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 169. ITALY CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 170. ITALY CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 171. ITALY CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 172. NETHERLANDS CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 173. NETHERLANDS CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 174. NETHERLANDS CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 175. NETHERLANDS CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 176. NETHERLANDS CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 177. NIGERIA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 178. NIGERIA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 179. NIGERIA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 180. NIGERIA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 181. NIGERIA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 182. NORWAY CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 183. NORWAY CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 184. NORWAY CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 185. NORWAY CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 186. NORWAY CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 187. POLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 188. POLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 189. POLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 190. POLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 191. POLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 192. QATAR CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 193. QATAR CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 194. QATAR CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 195. QATAR CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 196. QATAR CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 198. RUSSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 199. RUSSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 200. RUSSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 201. RUSSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 202. SAUDI ARABIA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 204. SAUDI ARABIA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 205. SAUDI ARABIA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 206. SAUDI ARABIA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 208. SOUTH AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 209. SOUTH AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 210. SOUTH AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 211. SOUTH AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 212. SPAIN CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 213. SPAIN CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 214. SPAIN CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 215. SPAIN CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 216. SPAIN CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 217. SWEDEN CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 218. SWEDEN CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 219. SWEDEN CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 220. SWEDEN CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 221. SWEDEN CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 222. SWITZERLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 223. SWITZERLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 224. SWITZERLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 225. SWITZERLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 226. SWITZERLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 227. TURKEY CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 228. TURKEY CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 229. TURKEY CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 230. TURKEY CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 231. TURKEY CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 236. UNITED ARAB EMIRATES CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 238. UNITED KINGDOM CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 240. UNITED KINGDOM CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 242. CLINICAL TRIAL IMAGING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 243. CLINICAL TRIAL IMAGING MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

  • Alimentiv Inc.
  • Anagram 4 Clinical Trials
  • Biospective Inc.
  • Boston Imaging Core Lab LLC
  • Cardiovascular Imaging Technologies LLC
  • Clario
  • GE HealthCare Technologies Inc.
  • Icon PLC
  • Image Core Lab Private Limited
  • Imaging Endpoints II LLC
  • Ixico PLC
  • Median Technologies
  • Medical Metrics Inc. by Catalent, Inc.
  • Medidata by Dassault Systèmes
  • Medpace, Inc.
  • Micron Inc.
  • Perceptive Informatics LLC
  • ProScan Imaging LLC
  • Resonance Health Ltd.
  • Voiant Clinical
  • WCG Clinical, Inc.

Methodology

Loading
LOADING...

Table Information